Hao Yin

Hao Yin

Auto-generated profile, based on publicly available information

Hao Yin

Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, #16369 Jingshi Road, Jinan 250011, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2023 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
JGJian Gao
Jian Gao
HYHao Yin
Hao Yin
YDYanqun Dong
Yanqun Dong
XWXintong Wang
Xintong Wang
YLYani Liu
Yani Liu
KWKewei Wang
Kewei Wang
A uricosuric drug benzbromarone, widely used for treatment of gout, hyperpolarizes the membrane potential of airway smooth muscle cells, but how it works remains unknown. Here we show a novel role of benzbromarone in activation of large conductance calcium-activated K+ channels. Benzbromarone results in dose-dependent activation of macroscopic BK currents about 1.7 to 14.5 folds with an EC50 of 111 μM and shifts the voltage-dependent channel activation to a more hyperpolarizing direction about 10 to 54 mV in whole-cell patch clamp recordings. In single-channel recordings, benzbromarone decreases single BKα channel closed dwell time and increases the channel open probability. Co-expressing β1 subunit also enhances BK activation by benzbromarone with an EC50 of 67 μM and a leftward shift of G-V curve about 44 to 138 mV. Site-directed mutagenesis reveals that a motif of three amino acids 329RKK331 in the cytoplasmic linker between S6 and C-terminal RCK gating ring mediates the pharmacological activation of BK channels by benzbromarone. Further ex vivo assay shows that benzbromarone causes reduction of tracheal strip contraction. Taken together, our findings demonstrate that uricosuric benzbromarone activates BK channels through molecular mechanism of action involving the channel RKK motif of S6-RCK linker. Pharmacological activation of BK channel by benzbromarone causes reduction of tracheal strip contraction, holding a repurposing potential for asthma and pulmonary arterial hypertension or BK channelopathies. Significance Statement We describe a novel role of uricosuric agent benzbromarone in BK channel activation and relaxation of airway smooth muscle contraction. In this study, we find that benzbromarone is an activator of the large-conductance Ca2+- and voltage-activated K+ channel (BK channel) that serves numerous cellular functions including control of smooth muscle contraction. Pharmacological activation of BK channel by an FDA approved drug benzbromarone may hold repurposing potential for treatment of asthma and pulmonary arterial hypertension or BK channeopathies.

22 November 2024 in Environmental Pollution
Verified
Journal Article
Closed access
HYHao Yin
Hao Yin
YZYaoyao Zheng
Yaoyao Zheng
MCMenghan Chen
Menghan Chen
MDMing Ding
Ming Ding
LZLin Zhang
Lin Zhang
XLXiaoqian Liu
Xiaoqian Liu